AMT could stop ulceration

Article

Amniotic membrane transplantation (AMT) may stop corneal ulceration and promote epithelialization, according to an investigation.

Amniotic membrane transplantation (AMT) may stop corneal ulceration and promote epithelialization, according to an investigation.

Dr Stanislav A. Iakimenko et al., Department of Eye Burns, Ophthalmic Plastic Surgery, Keratoplasty and Keratoprosthesis, State Institution,The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine, Ukraine, analysed the results of 55 AMTs in 53 eyes of 53 patients.

All patients had corneal ulceration and limbal deficiency 180-360° of the limbus after grade 4-6 chemical and thermal injuries was performed. The preoperative visual acuity (VA) was

The findings showed that corneal ulceration was prevented in 98.1% of cases and corneas were epithelialized in 76.3% of AMTs. Corneal defect recurred in 7.1% of successful cases and VA was ≥0.01 in 54.8% of patients after corneal epithelialization.

VA at the last follow-up visit improved on 2 or more lines on the eye chart, compared to preoperative VA in 35.7% with corneal epithelialization. VA didn’t improve in 42.9% of successful patients and it reduced by one line in 26.2% of patients.

Please visit the latest online issue of the European Journal of Ophthalmology to see the abstract.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.